3D Systems Corp (NYSE:DDD)
$ 3.02 -0.2 (-6.21%) Market Cap: 403.39 Mil Enterprise Value: 510.76 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 55/100

3D Systems Corp Acquisition of Volumetric Biotechnologies Call Transcript

Oct 28, 2021 / 02:00PM GMT
Release Date Price: $27.9 (+3.14%)
Operator

Hello, and welcome to the 3D Systems to Acquire Volumetric Biotechnologies Conference Call and Webcast. (Operator Instructions) As a reminder, this conference is being recorded.

It's now my pleasure to turn the call over to John Nypaver. Please go ahead.

John E. Nypaver
3D Systems Corporation - VP of IR & Treasurer

Thank you, Kevin. Good morning, and welcome to 3D Systems' conference call. With me on the call are Dr. Jeffrey Graves, our President and Chief Executive Officer; Jagtar Narula, Executive Vice President and Chief Financial Officer; and Dr. Jordan Miller, Co-Founder and President of Volumetric Biotechnologies.

We will begin with a set of prepared remarks, followed by a question-and-answer session. Note that the question-and-answer session will be limited only to today's topic on our regenerative medicine efforts and the acquisition of Volumetric Biotechnologies. Management is not in a position to answer questions on other topics, including our Q3 financial results, which we will report in our upcoming earnings release.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot